Literature DB >> 16627914

Cyclooxygenase-2 and thromboxane synthase in non-endocrine and endocrine tumors: a review.

Onder Onguru1, Mary B Casey, Sabine Kajita, Nobuki Nakamura, Ricardo V Lloyd.   

Abstract

Prostaglandins (PG) are members of a large group of hormonally active fatty acids derived from free fatty acids. They are formed from arachidonic acid-the major PG precursor. Cyclooxygenase (COX)-1 and -2 are the rate-limiting steps in PG synthesis. COX-2 is overexpressed in many human non-endocrine and endocrine tumors including colon, breast, prostate, brain, thyroid, and pituitary. COX-2 has an important role in angiogenesis and tumor growth. Thromboxane synthase (TS) catalyzes the synthesis of thromboxane A2 (TXA2), which is derived from arachidonic acid and prostaglandin H2 and is a vasoconstrictor and inducer of platelet aggregation. TXA2 stimulates tumor growth and spread of some tumors and TS appears to have a critical role in tumorigenesis in some organ systems. In this review, we examine the role of COX-2 and TS in various non-endocrine tumors, especially colon, breast, prostate, and brain as well as in endocrine tumors. The accumulating evidence points to an increasingly important role of COX-2 and TS in tumor progression and metastasis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16627914     DOI: 10.1385/ep:16:4:253

Source DB:  PubMed          Journal:  Endocr Pathol        ISSN: 1046-3976            Impact factor:   3.943


  155 in total

Review 1.  Cyclooxygenases: structural, cellular, and molecular biology.

Authors:  W L Smith; D L DeWitt; R M Garavito
Journal:  Annu Rev Biochem       Date:  2000       Impact factor: 23.643

2.  Ibuprofen-induced inhibition of cyclooxygenase isoform gene expression and regression of rat mammary carcinomas.

Authors:  F M Robertson; M L Parrett; F S Joarder; M Ross; H M Abou-Issa; G Alshafie; R E Harris
Journal:  Cancer Lett       Date:  1998-01-09       Impact factor: 8.679

3.  Enhanced cyclooxygenase-2 expression in sporadic and familial adenomatous polyposis of the human colon.

Authors:  K N Khan; J L Masferrer; B M Woerner; R Soslow; A T Koki
Journal:  Scand J Gastroenterol       Date:  2001-08       Impact factor: 2.423

4.  TIS10, a phorbol ester tumor promoter-inducible mRNA from Swiss 3T3 cells, encodes a novel prostaglandin synthase/cyclooxygenase homologue.

Authors:  D A Kujubu; B S Fletcher; B C Varnum; R W Lim; H R Herschman
Journal:  J Biol Chem       Date:  1991-07-15       Impact factor: 5.157

5.  Cytoplasmic induction and over-expression of cyclooxygenase-2 in human prostate cancer: implications for prevention and treatment.

Authors:  S Madaan; P D Abel; K S Chaudhary; R Hewitt; M A Stott; G W Stamp; E N Lalani
Journal:  BJU Int       Date:  2000-10       Impact factor: 5.588

6.  Why is cyclooxygenase-2 expressed in neuroendocrine cells of the human alimentary tract?

Authors:  T Nakajima; K Hamanaka; T Fukuda; T Oyama; K Kashiwabara; T Sano
Journal:  Pathol Int       Date:  1997-12       Impact factor: 2.534

7.  Patterns of cyclooxygenase-1 and -2 expression in human gliomas in vivo.

Authors:  M H Deininger; M Weller; J Streffer; M Mittelbronn; R Meyermann
Journal:  Acta Neuropathol       Date:  1999-09       Impact factor: 17.088

8.  Differential expression of cyclooxygenase-2 and its regulation by tumor necrosis factor-alpha in normal and malignant prostate cells.

Authors:  V Subbarayan; A L Sabichi; N Llansa; S M Lippman; D G Menter
Journal:  Cancer Res       Date:  2001-03-15       Impact factor: 12.701

9.  Overexpression of cyclooxygenase-2 is associated with breast carcinoma and its poor prognostic factors.

Authors:  Jeong Yun Shim; Hee Jung An; Yong Hee Lee; Seung Ki Kim; Kyong Po Lee; Kyong Sik Lee
Journal:  Mod Pathol       Date:  2003-12       Impact factor: 7.842

10.  Analysis of cyclooxygenase-2 expression in human breast cancer: high throughput tissue microarray analysis.

Authors:  Pia Wülfing; Raihanatou Diallo; Christine Müller; Christian Wülfing; Christopher Poremba; Achim Heinecke; Achim Rody; Robert R Greb; Werner Böcker; Ludwig Kiesel
Journal:  J Cancer Res Clin Oncol       Date:  2003-07-15       Impact factor: 4.553

View more
  7 in total

1.  Urinary thromboxane B2 and thromboxane receptors in bladder cancer: opportunity for detection and monitoring.

Authors:  Omar Moussa; Andrew Ciupek; Dennis K Watson; Perry V Halushka
Journal:  Prostaglandins Other Lipid Mediat       Date:  2011-09-29       Impact factor: 3.072

2.  A simple, quick, and high-yield preparation of the human thromboxane A2 receptor in full size for structural studies.

Authors:  Ke-He Ruan; Vanessa Cervantes; Jiaxin Wu
Journal:  Biochemistry       Date:  2008-06-05       Impact factor: 3.162

3.  Heritability of thromboxane A2 and prostaglandin E2 biosynthetic machinery in a Spanish population.

Authors:  Luis Vila; Angel Martinez-Perez; Mercedes Camacho; Alfonso Buil; Sonia Alcolea; Nuria Pujol-Moix; Marta Soler; Rosa Antón; Juan-Carlos Souto; Jordi Fontcuberta; José-Manuel Soria
Journal:  Arterioscler Thromb Vasc Biol       Date:  2009-10-22       Impact factor: 8.311

4.  Expression of cyclooxygenase-2 (COX-2) in pituitary tumours.

Authors:  Grzegorz Sokołowski; Agata Bałdys-Waligórska; Małgorzata Trofimiuk; Dariusz Adamek; Alicja Hubalewska-Dydejczyk; Filip Gołkowski
Journal:  Med Sci Monit       Date:  2012-04

5.  Quercetin suppresses cyclooxygenase-2 expression and angiogenesis through inactivation of P300 signaling.

Authors:  Xiangsheng Xiao; Dingbo Shi; Liqun Liu; Jingshu Wang; Xiaoming Xie; Tiebang Kang; Wuguo Deng
Journal:  PLoS One       Date:  2011-08-08       Impact factor: 3.240

6.  Crosstalk between osteoprotegerin (OPG), fatty acid synthase (FASN) and, cycloxygenase-2 (COX-2) in breast cancer: implications in carcinogenesis.

Authors:  Sudeshna Goswami; Neelam Sharma-Walia
Journal:  Oncotarget       Date:  2016-09-13

7.  NFAT regulates induction of COX-2 and apoptosis of keratinocytes in response to ultraviolet radiation exposure.

Authors:  R J Flockhart; B L Diffey; P M Farr; J Lloyd; N J Reynolds
Journal:  FASEB J       Date:  2008-08-15       Impact factor: 5.191

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.